|
G |
P2RY2 |
purinergic receptor P2Y2 |
multiple interactions |
EXP |
[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP] |
CTD |
PMID:10604969 |
|
NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
|
|
|
G |
CDIPT |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
multiple interactions |
EXP |
[delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Hexachlorocyclohexane affects the activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate |
CTD |
PMID:2579070 |
|
NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
|
|
|
G |
CFTR |
CF transmembrane conductance regulator |
multiple interactions |
EXP |
[1-Methyl-3-isobutylxanthine co-treated with 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP] results in increased activity of CFTR protein |
CTD |
PMID:15161604 |
|
NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
|
|
|
G |
CDIPT |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
multiple interactions |
EXP |
[delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Hexachlorocyclohexane affects the activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate |
CTD |
PMID:2579070 |
|
NCBI chr 6:17,910,141...17,914,573
Ensembl chr 6:17,910,192...17,914,653
|
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
increases expression |
EXP |
Tunicamycin results in increased expression of HSP90B1 protein |
CTD |
PMID:17416481 |
|
NCBI chr15:42,456,793...42,474,122
Ensembl chr15:42,456,764...42,579,311
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
EXP |
Tunicamycin results in increased expression of HSPA5 protein |
CTD |
PMID:17416481 |
|
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
|
|
|
G |
P2RY2 |
purinergic receptor P2Y2 |
multiple interactions increases activity |
EXP |
[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid; [Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Arachidonic Acid]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [[Uridine Triphosphate results in increased activity of P2RY2 protein] which results in increased abundance of Cyclic AMP] |
CTD |
PMID:10604969 |
|
NCBI chr21:24,987,568...25,009,754
Ensembl chr21:24,992,848...24,996,059
|
|